Evidence map›Paper›PMID 31302748›Full record

ReviewCellular and molecular life sciences : CMLS2019

The Tousled-like kinases regulate genome and epigenome stability: implications in development and disease.

Sandra Segura-Bayona, Travis H Stracker

Open access · greenAbstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. iScience · 2024
    Article
  16. Article
  17. Article
  18. Review
  19. The interaction betweenAnnals of medicine · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Sandra Segura-BayonaDepartment of Oncology, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, C/Baldiri Reixac 10, 08028, Barcelona, Spain. sandra.segura-bayona@crick.ac.uk.ORCID http://orcid.org/0000-0001-7788-9889
Travis H StrackerDepartment of Oncology, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, C/Baldiri Reixac 10, 08028, Barcelona, Spain. travis.stracker@irbbarcelona.org.ORCID http://orcid.org/0000-0002-8650-2081
Institute for Research in Biomedicine · ESThe Francis Crick Institute · GB

Funding

Fundacio La Caixa LCF/PR/GN14/10270002Ministry of Science, Innovation and Universities GINDATA
6 · The paper itself

Abstract

The Tousled-like kinases (TLKs) are an evolutionarily conserved family of serine-threonine kinases that have been implicated in DNA replication, DNA repair, transcription, chromatin structure, viral latency, cell cycle checkpoint control and chromosomal stability in various organisms. The functions of the TLKs appear to depend largely on their ability to regulate the H3/H4 histone chaperone ASF1, although numerous TLK substrates have been proposed. Over the last few years, a clearer picture of TLK function has emerged through the identification of new partners, the definition of specific roles in development and the elucidation of their structural and biochemical properties. In addition, the TLKs have been clearly linked to human disease; both TLK1 and TLK2 are frequently amplified in human cancers and TLK2 mutations have been identified in patients with neurodevelopmental disorders characterized by intellectual disability (ID), autism spectrum disorder (ASD) and microcephaly. A better understanding of the substrates, regulation and diverse roles of the TLKs is needed to understand their functions in neurodevelopment and determine if they are viable targets for cancer therapy. In this review, we will summarize current knowledge of TLK biology and its potential implications in development and disease.

Indexed as

Genomic InstabilityAnimalsEpigenesis, GeneticHumansMiceNeoplasmsNeurodevelopmental DisordersProtein DomainsProtein KinasesProtein Serine-Threonine KinasesProtein Kinasesprotein kinase UProtein Serine-Threonine KinasesTLK1 protein, humanASF1AASF1BCancerCell cycle checkpointDNA repairDNA replicationEpigeneticsGenome instabilityHistone chaperoneKinaseNeurodevelopmental disorderTLK1TLK2

Identifiers

PMID31302748
PMCPMC11105529
OpenAlexW2957761899

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.